ArticleJournal of translational internal medicine2024

RN486, a Bruton's Tyrosine Kinase inhibitor, antagonizes multidrug resistance in ABCG2-overexpressing cancer cells.

Xing-Duo Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.